Latest News

ViiV reaches another milestone

ViiV reaches another milestone

ViiV reaches another milestone in the development of a long-acting HIV regimen

ViiV reaches another milestone in the development of a long-acting HIV regimen

FDA grants fast-track status for Ablynx’s caplacizumab to treat aTTP

Belgian biopharmaceutical company Ablynx has received fast-track designation from the US Food and Drug Administration (FDA) for its caplacizumab treatment for acquired thrombotic...

FDA grants fast-track status for Ablynx’s caplacizumab to treat aTTP

Sandoz to improve treatment access to children with cancer in four developing nations

Novartis Group division Sandoz has expanded its partnership with UK-based charity World Child Cancer to improve access to treatment, as well as optimise survival outcomes for children...

Sandoz to improve treatment access to children with cancer in four developing nations

New study discovers faulty genes underlying brain tumours

New study discovers faulty genes underlying brain tumours

Antabio to develop treatment for Pseudomonas infections in cystic fibrosis patients

French biopharmaceutical company Antabio has secured a non-dilutive funding to accelerate the development of a new small molecule drug to treat chronic Pseudomonas infections in cystic...

Antabio to develop treatment for Pseudomonas infections in cystic fibrosis patients

GSK files supplementary NDA for asthma treatment arnuity ellipta

GSK files supplementary NDA for asthma treatment arnuity ellipta

STA Pharmaceutical signs deal with Tesaro for zejula

STA Pharmaceutical, a subsidiary of China-based company WuXi AppTec with facilities in China and the US, has signed a new supply agreement with oncology-focused biopharmaceutical company Tesaro...

STA Pharmaceutical signs deal with Tesaro for zejula

Janssen receives EMA committee recommendation to market Symtuza for HIV

Janssen-Cilag International (Janssen) has received a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommending...

Janssen receives EMA committee recommendation to market Symtuza for HIV

Mitsubishi Tanabe Pharma to buy NeuroDerm for $1.1bn

Japan’s Mitsubishi Tanabe Pharma (MTPC) has entered a new definitive agreement to acquire all of the outstanding shares of Israel-based pharmaceutical company NeuroDerm for $1.1bn in...

Mitsubishi Tanabe Pharma to buy NeuroDerm for $1.1bn

Lilly and Nektar partner to develop new immunological therapy NKTR-358

Lilly and Nektar partner to develop new immunological therapy NKTR-358

EMA’s CHMP recommends Merck and Pfizer's cancer drug avelumab for approval

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of Merck and Pfizer's avelumab (BAVENCIO) as...

EMA’s CHMP recommends Merck and Pfizer's cancer drug avelumab for approval

Recipharm and LIDDS set up prostate cancer drug development facility in Sweden

Recipharm, a Swedish contract development and manufacturing organisation (CDMO), and LIDDS have jointly established an industrial manufacturing line to develop new prostate cancer drug, Liproca...

Recipharm and LIDDS set up prostate cancer drug development facility in Sweden

NICE approves new tolerable drug carflizomib for multiple myeloma patients on NHS

NICE approves new tolerable drug carflizomib for multiple myeloma patients on NHS

Deals this week: Hugel, Guangdong Zhongsheng Pharmaceutical, Valeant Pharmaceuticals International

South Korean pharmaceutical company Hugel has announced the private placement of 985,217 common stock shares priced at KRW360,001.9 ($316.2) a share to raise KRW354.68bn ($311.52m) in gross...

Deals this week: Hugel, Guangdong Zhongsheng Pharmaceutical, Valeant Pharmaceuticals International

M&As this week: Northeast Pharmaceutical Group, Principia SGR, Commelina

Chinese pharmaceutical company Northeast Pharmaceutical Group plans to acquire 60% stake in a medicine company based in Dandong, China, through its subsidiary for CNY3.9m...

M&As this week: Northeast Pharmaceutical Group, Principia SGR, Commelina

NICE recommends Teva’s Cinqaero to treat severe eosinophilic asthma

The UK National Institute for Health and Care Excellence (NICE) has recommended Teva Pharmaceutical Industries’ Cinqaero (reslizumab) for the treatment of patients with severe eosinophilic...

NICE recommends Teva’s Cinqaero to treat severe eosinophilic asthma

Ablynx and Sanofi collaborate for nanobody-based inflammatory disease treatments

Belgian biopharmaceutical company Ablynx has entered a research collaboration and global exclusive licensing agreement with French firm Sanofi to develop and commercialise...

Ablynx and Sanofi collaborate for nanobody-based inflammatory disease treatments

Elsalys Biotech and DKFZ collaborate to develop ELB021 in B-Cell leukaemia

Elsalys Biotech has entered a preclinical collaboration with German cancer research institute DKFZ to initiate the development of ELB021 in B-Cell leukaemia, under European Union (EU)...

Elsalys Biotech and DKFZ collaborate to develop ELB021 in B-Cell leukaemia

Gilead’s Vosevi receives FDA approval for re-treatment of chronic HCV

Gilead’s Vosevi receives FDA approval for re-treatment of chronic HCV

GSK to invest additional £140m at UK manufacturing sites

GlaxoSmithKline (GSK) is set to invest more than £140m at its production facilities in the UK to improve the efficiency and competitiveness of its manufacturing...

GSK to invest additional £140m at UK manufacturing sites
cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1460672566_rd1460672566_371857150_ap1460672566_1857678299_946450448